Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Use formulas for budget calculations to automate totals, forecast outcomes, and reveal spending patterns with confidence.
10,965 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...
AI's energy appetite is growing. This article explains how these energy stocks helping power AI’s rise and what it me...
Ripple faces a pivotal week as XRP tests critical support near $1 and resistance at $1.40. Analysts publish ripple (x...
A standout earnings beat pushed Clear Secure stock higher on Wednesday as revenue, user growth, and guidance surprise...
Could investing in Sandisk turn small bets into big gains? This grounded guide explains what works, what risks exist,...
This article breaks down Summit Hotel (Inn) earnings, translating quarterly results into actionable insights for inve...
Wix has endured a brutal stock down year, dropping roughly 70% as growth worries and macro headwinds hit software nam...
As TTEC heads into 2025 earnings season, investors want a clear view of what could drive the numbers. This guide brea...
Two years of rapid expansion can propel small innovators into the spotlight. This guide breaks down how to spot real ...
Sweetgreen faces a turning point after a tough year. This article examines if a 'wraps' strategy—bundled menu changes...
Brand resilience is a key factor for investors. This article examines Unity Software and Zillow to see if they stand ...